SAUVAGE PHILIPPE (Chief Financial Officer) purchased 280.6% of their position (7.30K shares) of NUVATION BIO INC. on the open market
Open‑market purchase worth $13.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/18/2025ACC: 0001415889-25-017659
Officer· Chief Financial Officer
Since Feb 2026
+7.30K
Net shares
Net buyer
$13.2K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
7.30K acquired
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+3.30K
Price / share
$1.83
Trade value
$6.06K
% of position
126.8%
6/16/2025
2.60K→5.90K
Class A Common Stock
Direct
Shares
+4K
Price / share
$1.79
Trade value
$7.16K
% of position
67.8%
6/17/2025
5.90K→9.90K
Total
Net shares
+7.30K
Net value
$13.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 6/16/2025 | P · Purchase | +3.30K | $1.83 | $6.06K | 126.8% | 2.60K | 5.90K |
| Class A Common Stock Direct | 6/17/2025 | P · Purchase | +4K | $1.79 | $7.16K | 67.8% | 5.90K | 9.90K |
| Total | +7.30K | $13.22K | ||||||
Derivative Transactions0
No derivative transactions reported